CANGO INC/KY-CLASS A (CANG) Fundamental Analysis & Valuation

NYSE:CANG • KYG1820C1024

0.7369 USD
+0.02 (+2.99%)
At close: Mar 4, 2026
0.75 USD
+0.01 (+1.78%)
After Hours: 3/4/2026, 8:11:58 PM

This CANG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CANG. CANG was compared to 123 industry peers in the Specialty Retail industry. While CANG seems to be doing ok healthwise, there are quite some concerns on its profitability. CANG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. CANG Profitability Analysis

1.1 Basic Checks

  • CANG had negative earnings in the past year.
  • The reported net income has been mixed in the past 5 years: CANG reported negative net income in multiple years.
  • In the past 5 years CANG reported 4 times negative operating cash flow.
CANG Yearly Net Income VS EBIT VS OCF VS FCFCANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • With a Return On Assets value of -166.79%, CANG is not doing good in the industry: 93.50% of the companies in the same industry are doing better.
  • CANG has a worse Return On Equity (-324.13%) than 76.42% of its industry peers.
  • With an excellent Return On Invested Capital value of 32.99%, CANG belongs to the best of the industry, outperforming 97.56% of the companies in the same industry.
Industry RankSector Rank
ROA -166.79%
ROE -324.13%
ROIC 32.99%
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
CANG Yearly ROA, ROE, ROICCANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • In the last couple of years the Profit Margin of CANG has grown nicely.
  • CANG has a Operating Margin of 15.51%. This is amongst the best in the industry. CANG outperforms 93.50% of its industry peers.
  • CANG's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CANG (8.55%) is worse than 90.24% of its industry peers.
  • In the last couple of years the Gross Margin of CANG has declined.
Industry RankSector Rank
OM 15.51%
PM (TTM) N/A
GM 8.55%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
CANG Yearly Profit, Operating, Gross MarginsCANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

5

2. CANG Health Analysis

2.1 Basic Checks

  • CANG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, CANG has about the same amount of shares outstanding.
  • The number of shares outstanding for CANG has been reduced compared to 5 years ago.
  • CANG has a worse debt/assets ratio than last year.
CANG Yearly Shares OutstandingCANG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CANG Yearly Total Debt VS Total AssetsCANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.50 indicates that CANG is not in any danger for bankruptcy at the moment.
  • CANG has a better Altman-Z score (3.50) than 78.86% of its industry peers.
  • CANG has a Debt/Equity ratio of 0.59. This is a neutral value indicating CANG is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.59, CANG perfoms like the industry average, outperforming 49.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACC3.75
WACC8.79%
CANG Yearly LT Debt VS Equity VS FCFCANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • CANG has a Current Ratio of 1.19. This is a normal value and indicates that CANG is financially healthy and should not expect problems in meeting its short term obligations.
  • CANG has a Current ratio of 1.19. This is comparable to the rest of the industry: CANG outperforms 40.65% of its industry peers.
  • CANG has a Quick Ratio of 1.19. This is a normal value and indicates that CANG is financially healthy and should not expect problems in meeting its short term obligations.
  • CANG's Quick ratio of 1.19 is fine compared to the rest of the industry. CANG outperforms 79.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
CANG Yearly Current Assets VS Current LiabilitesCANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2

3. CANG Growth Analysis

3.1 Past

  • CANG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2773.33%.
  • The earnings per share for CANG have been decreasing by -13.08% on average. This is quite bad
  • Looking at the last year, CANG shows a very strong growth in Revenue. The Revenue has grown by 1008.65%.
  • Measured over the past years, CANG shows a very negative growth in Revenue. The Revenue has been decreasing by -11.00% on average per year.
EPS 1Y (TTM)-2773.33%
EPS 3YN/A
EPS 5Y-13.08%
EPS Q2Q%150%
Revenue 1Y (TTM)1008.65%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%5854.4%

3.2 Future

  • CANG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -60.14% yearly.
  • CANG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.73% yearly.
EPS Next Y-294.41%
EPS Next 2Y-60.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.36%
Revenue Next 2Y-6.78%
Revenue Next 3Y-4.73%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CANG Yearly Revenue VS EstimatesCANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CANG Yearly EPS VS EstimatesCANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

1

4. CANG Valuation Analysis

4.1 Price/Earnings Ratio

  • CANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CANG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CANG Price Earnings VS Forward Price EarningsCANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • 96.75% of the companies in the same industry are more expensive than CANG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.69
CANG Per share dataCANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

  • CANG's earnings are expected to decrease with -60.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-60.14%
EPS Next 3YN/A

0

5. CANG Dividend Analysis

5.1 Amount

  • No dividends for CANG!.
Industry RankSector Rank
Dividend Yield 0%

CANG Fundamentals: All Metrics, Ratios and Statistics

CANGO INC/KY-CLASS A

NYSE:CANG (3/4/2026, 8:11:58 PM)

After market: 0.75 +0.01 (+1.78%)

0.7369

+0.02 (+2.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-01
Earnings (Next)03-05
Inst Owners6.53%
Inst Owner Change6.85%
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap76.48M
Revenue(TTM)2.95B
Net Income(TTM)-2.23B
Analysts82.5
Price Target3.06 (315.25%)
Short Float %10.76%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1499.62%
Min EPS beat(2)-3070.37%
Max EPS beat(2)71.13%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.27%
Min Revenue beat(2)2.11%
Max Revenue beat(2)12.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-62.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-486.68%
EPS NY rev (1m)20.71%
EPS NY rev (3m)60.36%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)-12.11%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA 1.69
EPS(TTM)-10.75
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.12
BVpS0.96
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -166.79%
ROE -324.13%
ROCE 41.76%
ROIC 32.99%
ROICexc 32.99%
ROICexgc 33%
OM 15.51%
PM (TTM) N/A
GM 8.55%
FCFM N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-6.32%
ROICexgc growth 5Y-14.8%
ROICexc growth 3Y-5.17%
ROICexc growth 5Y-14.28%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
F-ScoreN/A
Asset Turnover2.21
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 3.5
F-ScoreN/A
WACC8.79%
ROIC/WACC3.75
Cap/Depr(3y)348.58%
Cap/Depr(5y)264.99%
Cap/Sales(3y)38.63%
Cap/Sales(5y)23.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2773.33%
EPS 3YN/A
EPS 5Y-13.08%
EPS Q2Q%150%
EPS Next Y-294.41%
EPS Next 2Y-60.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1008.65%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%5854.4%
Revenue Next Year-20.36%
Revenue Next 2Y-6.78%
Revenue Next 3Y-4.73%
Revenue Next 5YN/A
EBIT growth 1Y1110.46%
EBIT growth 3Y-4.73%
EBIT growth 5Y-15.84%
EBIT Next Year94.91%
EBIT Next 3Y110.81%
EBIT Next 5YN/A
FCF growth 1Y-220.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-130.21%
OCF growth 3YN/A
OCF growth 5YN/A

CANGO INC/KY-CLASS A / CANG FAQ

What is the fundamental rating for CANG stock?

ChartMill assigns a fundamental rating of 3 / 10 to CANG.


What is the valuation status for CANG stock?

ChartMill assigns a valuation rating of 1 / 10 to CANGO INC/KY-CLASS A (CANG). This can be considered as Overvalued.


What is the profitability of CANG stock?

CANGO INC/KY-CLASS A (CANG) has a profitability rating of 2 / 10.


What is the expected EPS growth for CANGO INC/KY-CLASS A (CANG) stock?

The Earnings per Share (EPS) of CANGO INC/KY-CLASS A (CANG) is expected to decline by -294.41% in the next year.